David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
The GEO Group
GEO
$4.22B
| $9.13M | 0.01% |
339,582
-51,133
| -13% | -$1.41M |
|
977
Community Health Systems
CYH
$420M
| $9.13M | 0.01% |
1,188,680
-441,390
| -27% | -$3.44M |
|
978
Valmont Industries
VMI
$9.11B
| $9.12M | 0.01% |
57,663
+570
| +1% | +$85.9K |
|
979
iShares US Transportation ETF
IYT
$2.28B
| $9.11M | 0.01% |
+204,400
| New | +$8.68M |
|
980
Assured Guaranty
AGO
$3.3B
| $9.07M | 0.01% |
240,384
+104,493
| +77% | +$4.48M |
|
|
CBPO
981
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $9.05M | 0.01% |
98,134
+93,307
| +1,933% | +$8.97M |
|
982
CALL
Western Digital
WDC
$160B
| $9.03M | 0.01% |
138,254
-90,890
| -40% | -$6.03M |
|
983
Grand Canyon Education
LOPE
$3.91B
| $9.02M | 0.01% |
99,307
-63,328
| -39% | -$5.08M |
|
984
Avery Dennison
AVY
$13.6B
| $9.01M | 0.01% |
91,654
+89,287
| +3,772% | +$8.4M |
|
|
TIF
985
PUT
DELISTED
Tiffany & Co.
TIF
| $9M | 0.01% |
98,100
-3,300
| -3% | -$302K |
|
986
Open Text
OTEX
$5.89B
| $9M | 0.01% |
278,758
+124,700
| +81% | +$4.04M |
|
987
Lockheed Martin
LMT
$128B
| $8.97M | 0.01% |
28,926
+25,900
| +856% | +$7.73M |
|
988
Comfort Systems
FIX
$54.8B
| $8.97M | 0.01% |
251,212
+41,959
| +20% | +$1.45M |
|
989
PUT
TransDigm Group
TDG
$66B
| $8.95M | 0.01% |
35,000
+10,000
| +40% | +$2.71M |
|
|
CAI
990
DELISTED
CAI International, Inc.
CAI
| $8.95M | 0.01% |
295,108
+28,471
| +11% | +$786K |
|
|
PDLI
991
DELISTED
PDL BioPharma, Inc.
PDLI
| $8.94M | 0.01% |
2,636,405
+655,420
| +33% | +$1.82M |
|
992
CALL
Macy's
M
$5.95B
| $8.94M | 0.01% |
409,600
| – | – |
|
993
Ribbon Communications
RBBN
$368M
| $8.93M | 0.01% |
1,167,039
+27,964
| +2% | +$200K |
|
|
MASI
994
DELISTED
Masimo
MASI
| $8.93M | 0.01% |
103,114
-156,944
| -60% | -$13.9M |
|
995
Edgewell Personal Care
EPC
$1.32B
| $8.92M | 0.01% |
122,621
-1,873
| -2% | -$138K |
|
996
Perdoceo Education
PRDO
$2.1B
| $8.92M | 0.01% |
858,414
+135,156
| +19% | +$1.25M |
|
997
PUT
Vale
VALE
$64.7B
| $8.9M | 0.01% |
883,700
+460,000
| +109% | +$4.63M |
|
|
TMX
998
DELISTED
Terminix Global Holdings, Inc.
TMX
| $8.84M | 0.01% |
282,423
-290,505
| -51% | -$8.57M |
|
999
Seres Therapeutics
MCRB
$50.4M
| $8.8M | 0.01% |
27,437
+1,074
| +4% | +$294K |
|
1000
Green Dot
GDOT
$763M
| $8.77M | 0.01% |
178,022
+46,845
| +36% | +$2.08M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.